GlassScriptPhysician profile
Zarin Amin
NPI 1093971889
$998.45
in general payments reported to CMS, 2019-2025
18 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.58 · 2020: $15.03 · 2021: $116 · 2022: $171 · 2023: $188 · 2024: $199 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $208.33 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $163.57 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $88.63 | 2023-2024 | Delstrigo, Pifeltro, Dificid |
| Biogen, INC. | $81.98 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $71.78 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $64.21 | 2021-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Allergan, INC. | $48.92 | 2019 | |
| Stryker Corporation | $37.21 | 2025 | Flowtriever |
| Minerva Surgical, INC | $33.64 | 2025 | |
| Organon LLC | $33.37 | 2023-2025 | Nexplanon |
| Dexcom, INC. | $29.78 | 2025 | Dexcom G6 Transmitter |
| Amag Pharmaceuticals, INC. | $24.66 | 2019 | |
| Olympus America INC. | $22.13 | 2021 | |
| Ethicon US, LLC | $20.08 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.00 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.92 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.21 | 2025 | Exparel |
| Glaxosmithkline, LLC. | $15.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zarin Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.